Commonwealth Equity Services’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $78K | Sell |
|
|||||
|
2025
Q1 | $90K | Sell |
|
|||||
|
2024
Q4 | $140K | Sell |
|
|||||
|
2024
Q3 | $155K | Buy |
|
|||||
|
2024
Q2 | $18K | Sell |
|
|||||
|
2024
Q1 | $52K | Sell |
|
|||||
|
2023
Q4 | $152K | Sell |
|
|||||
|
2023
Q3 | $133K | Sell |
|
|||||
|
2023
Q2 | $221K | Hold |
|
|||||
|
2023
Q1 | $192 | Sell |
|
|||||
|
2022
Q4 | $137K | Sell |
|
|||||
|
2022
Q3 | $208K | Sell |
|
|||||
|
2022
Q2 | $185K | Sell |
|
|||||
|
2022
Q1 | $435K | Sell |
|
|||||
|
2021
Q4 | $1.02M | Buy |
|
|||||
|
2021
Q3 | $526K | Buy |
|
|||||
|
2021
Q2 | $590K | Buy |
|
|||||
|
2021
Q1 | $536K | Buy |
|
|||||
|
2020
Q4 | $274K | Buy |
|